Delivery Order SPE2DB24D2109-SPE2DB25FHWPP
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,476.62, is for the delivery of OLUMIANT 4 MG TABLET 30S, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,962.58 and a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, and it is part...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,272.35 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,637.63, is for the delivery of 4566066817 OLUMIANT 4 MG TABLET 30S, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle...
- This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $19,019.85, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, with a period of performance through June 16, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,633.37 firm fixed-price delivery order is for OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, the prime contractor, a firm fixed price delivery order contract valued at $3,549.10 to provide OLUMIANT 2 MG TABLET 30S to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $17,226.29 firm fixed-price delivery order is for OLUMIANT 4 MG TABLET 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of June 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN1C4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,015.93 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OLUMIANT 4 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $17,522.37 and is set to expire on August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which covers the delivery of a wide range of...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHWPPDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,397.99, is for the delivery of OLUMIANT 2 MG TABLET 30S, a medication used in the treatment of certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 3/18/25 |